ISSN: 2456-8058 (Online); 2831-5235 (Print) CODEN (CAS-USA): UJPRA3 CrossRef DOI Prefix: 10.22270/ujpr H5 Index (Google Scholar): 24 Membership: ICMJE, PORTICO, CrossRef Index Copernicus, ICV 2022: 100 |
NLM ID: 101711198 |
Publisher: Society of Pharmaceutical Technocrats (SoPhTec) Frequency: 6 Issues/Year ESTD Year: 2016 Email: editor@ujpronline.com Phone: +91-9997722274 Double-Blind Peer-reviewed |
The International, bimonthly, double-blind, peer-reviewed Universal Journal of Pharmaceutical Research (UJPR) is an open access journal that publishes original research papers, scientific commentaries, opinions, review articles, and editorial commentary in the field of pharmaceutical sciences. UJPR aims to support scientific and pharmaceutical research activities connected to pharmaceutical education and research by fostering social connections among global pharmaceutical experts. It also updates the scientific knowledge of the international audience in the pharmaceutical forum. Our goal is to recognize distinguished scholars, investigators, and emerging scientists who contribute to the advancement of the pharmacy field. It serves as a platform for all students and pharmacy professionals to advance their knowledge in the various areas of pharmacy by offering insightful articles and other helpful resources to further their careers. Articles in this multidisciplinary field are invited, with an emphasis on subjects pertinent to drug development and discovery. UJPR's publishing policy aims to choose the papers that are most significant to the larger pharmacy community. We especially encourage multidisciplinary papers and those that tackle novel or developing areas of pharmacy.
The Publisher Society of Pharmaceutical Technocrats (SoPhTec) officially publishes the Universal Journal of Pharmaceutical Research (UJPR). The SoPhTec aims to promote and foster the study of pharmaceutical and medical sciences as well as their application.
Publish through UJPR to gain global recognition
- Distinguished scientists and educators from several nations serve as members of the editorial board.
- Constructive reviews from renowned scientists and professors.
- Regular articles have no page restrictions.
- Cross Ref provides a distinct DOI (Digital Object Identifier) for each published article.
- High visibility and indexed in more than 40 reputable indexing services, such as ICV, CASSI (American Chemical Society), ROAD, Sherpa Romeo, EZB, ZDB, WIKIDATA, OPENALEX, FATCAT etc.
Current Issue
JULY-AUGUST